Key Segments
By Technology
-
Polymerase Chain Reaction (PCR)
-
Next-Generation Sequencing (NGS)
-
Microarrays
-
In Situ Hybridization (ISH)
-
Others
By Product
-
Reagents & Kits
-
Instruments
-
Software & Services
By Application
-
Infectious Diseases
-
Oncology
-
Genetic Testing
-
Blood Screening
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Research & Academic Institutes
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: The Molecular Diagnostics Market is expected to grow at a CAGR of 9.07% during 2026–2035.
Ans: The market was valued at USD 18.26 Billion in 2025 and is projected to reach USD 43.50 Billion by 2035.
Ans: The key drivers of the Molecular Diagnostics Market include rising infectious diseases, increasing cancer prevalence, demand for early diagnosis, technological advancements, personalized medicine adoption, and growing healthcare infrastructure globally.
Ans: The Polymerase Chain Reaction (PCR) segment dominated during the projected period.
Ans: North America dominated the Molecular Diagnostics Market in 2025.